Amgen (AMGN) Change in Taxes (2009 - 2026)

Amgen's Change in Taxes history runs 18 years deep, the most recent figure standing at $71.0 million for Q1 2026.

• In Q1 2026, Change in Taxes fell 31.73% year-over-year to $71.0 million; the TTM figure through Mar 2026 stood at -$2.1 billion (down 85.93% YoY), while the FY2025 annual figure was -$2.1 billion, down 104.55% from the prior year.
• Change in Taxes for Q1 2026 stood at $71.0 million, up from -$365.0 million in the prior quarter.
• The five-year high for Change in Taxes was $610.0 million in Q3 2025, with the low at -$2.4 billion in Q2 2025.
• The 5-year median for Change in Taxes is $71.0 million (2026), against an average of -$275.6 million.
• The sharpest annual moves came in 2022 and 2024: Change in Taxes soared 511.54% in 2022, then sank 5578.57% in 2024.
• Amgen's Change in Taxes stood at -$155.0 million in 2022, then plunged by 1209.03% to -$2.0 billion in 2023, then soared by 102.61% to $53.0 million in 2024, then sank by 788.68% to -$365.0 million in 2025, then soared by 119.45% to $71.0 million in 2026.
• Business Quant data shows AMGN's Change in Taxes at $71.0 million in Q1 2026, -$365.0 million in Q4 2025, and $610.0 million in Q3 2025.